Document is current
Any future updates will be listed below
-
Authors
Tang, Lin-Quan
Li, Xiao-Yun
Li, Zhi-Ming
Liu, Zhi-Gang
Lin, Miao-Zhen
Zhou, Huan
Yu, Qi-Wen
Zhou, Jian
Zhao, Chong
Chen, Ze-Bin
Wang, Xi-Cheng
Peng, Jia-Yu
Chen, Qiu-Yan
Fang, Wen-Feng
Yang, Yun-Peng
Zhang, Bei
Xia, Liang-Ping
Hu, Pi-Li
Hu, Wei-Han
Li, Yi-Jie
Mai, Hai-Qiang
Cai, Xiu-Yu
-
Funding
Funding for this research was provided by:
Chinese Society of Clinical Oncology (Y-HR2017-046)
the National Key R&D Program of China (2017YFC0908500, 2017YFC1309003)
National Natural Science Foundation of China (No. 81425018, No. 81672868, No.81802775, No. 82073003, No.82002852, No.82003267, No.81803105)
Guangzhou Municipal Science and Technology Project (201707020039)
the Sun Yat-sen University Clinical Research 5010 Program (No.2016010, No. 201315, No.2015021, No.2017010, No.2016013, No.2019023)
Innovative research team of high-level local universities in Shanghai (SSMU-ZLCX20180500)
Natural Science Foundation of Guangdong Province for Distinguished Young Scholars (No. 2018B030306001)
Natural Science Foundation of Guangdong Province (No.2017A030312003, No.2018A0303131004)
Health Medical Collaborative Innovation Program of Guangzhou (No.201803040003)
Pearl River S and T Nova Program of Guangzhou (201806010135)
Science and Technology Planning Project of Guangdong Province (2019B020230002)
Young Teacher Foundation of Sun Yat-sen University (20ykzd24)
- License Information
-
More Information
Article History
Received: 16 August 2022
Accepted: 16 February 2023
First Online: 16 March 2023
Declarations
:
: This study was approved by the Ethics Committee of SYSUCC (approval ID: B2018-055–01; B2018-055–02), and the study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent upon enrollment.
: Not applicable.
: The authors declare that they have no competing interests.
